| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.0052 |
0.9 |
| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |